RANTES/CCL5 gene polymorphisms, serum concentrations, and incident type diabetes: Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002

European Journal of Endocrinology

Volumn 158, Issue 5, 2008, Pages

  Herder, Christian ^a   Illig, Thomas ^b   Baumert, Jens ^b   Müller, Martina ^b,c   Klopp, Norman ^b   Khuseyinova, Natalie ^d   Meisinger, Christa ^b   Poschen, Ulrike ^a   Martin, Stephan ^a   Koenig, Wolfgang ^d   Thorand, Barbara ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RANTES;

ADIPOSE TISSUE; ALLELE; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HYPERGLYCEMIA; INCIDENCE; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; CHEMOKINE CCL5; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HAPLOTYPES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES;

EID: 43149111488     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0686     Document Type: Article

References (16)

1. Appay V & Rowland-Jones SL. RANTES: a versatile and controversial chemokine. Trends in Immunology 2001 22 83-87.
2. Poulain-Godefroy O & Froguel P. Preadipocyte response and impairment of differentiation in an inflammatory environment. Biochemical and Biophysical Research Communications 2007 356 662-667.
3. Wu H, Ghosh S, Perrard XD, Feng L, Garcia GE, Perrard JL, Sweeney JF, Peterson LE, Chan L, Smith CW & Ballantyne CM. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 2007 115 1029-1038.
4. Nomura S, Shouzu A, Omoto S, Nishikawa M & Fukuhara S. Significance of chemokines and activated platelets in patients with diabetes. Clinical and Experimental Immunology 2000 121 437-443.
5. Herder C, Haastert B, Muller-Scholze S, Koenig W, Thorand B, Holle R, Wichmann HE, Scherbaum WA, Martin S & Kolb H. Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey S4 (KORA S4). Diabetes 2005 54 (Supplement 2) S11-S17.
6. Herder C, Peltonen M, Koenig W, Kraft I, Muller-Scholze S, Martin S, Lakka T, Ilanne-Parikka P, Eriksson HG, Hamalainen H, Keinanen-Kiukaanniemi S, Valle TT, Uusitupa M, Lindstrom J, Kolb H & Tuomilehto J. Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes: results from the Finnish Diabetes Prevention Study. Diabetes 2006 55 2340-2346.
7. Herder C, Baumert J, Thorand B, Koenig W, de Jager W, Meisinger C, Illig T, Martin S & Kolb H. Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984-2002. Diabetologia 2006 49 921-929.
8. Thorand B, Baumert J, Kolb H, Meisinger C, Chabless L, Koenig W & Herder C. Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Diabetes Care 2007 30 854-860.
9. Herder C, Klopp N, Baumert J, Muller M, Khuseyinova N, Meisinger C, Martin S, Illig T, Koenig W & Thorand B. Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA /KORA Augsburg case-cohort study, 1984-2002. Diabetologia 2008 51 276-284.
10. Li J & Ji L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 2005 95 221-227.
11. R Development Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org, 2006.
12. Zhernakova A, Alizadeh BZ, Eerligh P, Hanifi-Moghaddam P, Schloot NC, Diosdado B, Wijmenga C, Roep BO & Koeleman BPC. Genetic variants of RANTES are associated with serum RANTES levels and protection for type 1 diabetes. Genes and Immunity 2006 7 544-549.
13. Jang Y, Chae JS, Hyun YJ, Koh SJ, Kim JY, Ko MJ, Rim SJ, Shin HJ, Ordovas JM & Lee JH. The RANTES -403G>A promoter polymorphism in Korean men: association with serum RANTES and coronary artery disease. Clinical Science 2007 113 349-356.
14. Nakajima K, Tanaka Y, Nomiyama T, Ogihara T, Ikeda F, Kanno R, Iwashita N, Sakai K, Watada H, Onuma T & Kawamori R. RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects. Diabetes Care 2003 26 892-898.
15. Simeoni E, Winkelmann BR, Hoffmann MM, Fleury S, Ruiz J, Kappenberger L, März W & Vassalli G. Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis. European Heart Journal 2004 25 1378-1381.
16. Thorand B, Kolb H, Baumert J, Koenig W, Chambless W, Meisinger C, Illig T, Martin S & Herder C. Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984-2002. Diabetes 2005 54 2932-2938.